Income Statement
AXSOME THERAPEUTICS, INC.
AXSM
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY |
|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
638.50 | 385.69 | 270.60 | 50.04 | - | - | - | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - | - | - | - | - | - |
|
Gross Profit
|
638.50 | 385.69 | 270.60 | 50.04 | - | - | - | - | - | - |
|
Operating Expenses
|
753.88 | 598.44 | 421.07 | 217.20 | 124.71 | 99.14 | 67.25 | 32.85 | 27.16 | 27.54 |
|
Research & Development
|
183.28 | 187.08 | 97.94 | 57.95 | 58.06 | 70.24 | 53.65 | 23.50 | 19.96 | 21.20 |
|
Selling, General & Administrative
|
570.60 | 411.36 | 323.12 | 159.25 | 66.65 | 28.90 | 13.60 | 9.35 | 7.21 | 6.34 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-115.38 | -212.74 | -150.47 | -167.16 | -124.71 | -99.14 | -67.25 | -32.85 | -27.16 | -27.54 |
|
Non-Operating Income
|
68.32 | 74.39 | 87.81 | - | - | - | - | - | - | - |
|
Interest Income
|
9.37 | 15.01 | - | - | - | - | - | - | - | - |
|
Interest Expense
|
-15.93 | -21.58 | - | - | - | - | - | - | - | - |
|
Other Non-Op Income / Expense
|
- | - | - | - | - | - | - | - | - | - |
|
Income Before Tax
|
-183.70 | -287.13 | -238.28 | - | - | - | - | - | - | - |
|
Income Tax Expense
|
-0.53 | 0.09 | 0.96 | - | - | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - |
|
Net Income
|
-183.17 | -287.22 | -239.24 | -187.13 | -130.40 | -102.90 | -68.35 | -30.97 | -28.94 | -27.20 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY |
|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-115.38 | -212.74 | -150.47 | -167.16 | -124.71 | -99.14 | -67.25 | -32.85 | -27.16 | -27.54 |
|
Earnings Per Share (Basic)
|
-3.68 | -5.99 | -5.27 | -4.60 | - | - | - | - | - | - |
|
Diluted EPS
|
-3.68 | -5.99 | -5.27 | -4.60 | - | - | - | - | - | - |
|
Weighted Average Shares
|
49.75 | 47.91 | 45.43 | 40.66 | - | - | - | - | - | - |
|
Diluted Weighted Avg Shares
|
49.75 | 47.91 | 45.43 | 40.66 | - | - | - | - | - | - |
|
Comprehensive Income
|
- | - | - | - | - | - | - | - | - | - |